Exelon and Hyperglycemia - a phase IV clinical study of FDA data

Summary:

Hyperglycemia is reported as a side effect among people who take Exelon (rivastigmine tartrate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Cymbalta, and have High blood pressure.

The phase IV clinical study analyzes which people have Hyperglycemia when taking Exelon. It is created by eHealthMe based on reports of 10,864 people who have side effects when taking Exelon from the FDA, and is updated regularly.

What is Exelon?

Exelon has active ingredients of rivastigmine tartrate. It is often used in alzheimer's disease. eHealthMe is studying from 11,060 Exelon users. Check the latest studies of Exelon.

What is Hyperglycemia?

Hyperglycemia (high blood sugar) is found to be associated with 1,657 drugs and 2,501 conditions by eHealthMe. Check the latest studies of Hyperglycemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

10,864 people reported to have side effects when taking Exelon.
Among them, 35 people (0.32%) have Hyperglycemia.

Among these 35 people:

How long have people been on Exelon when they have Hyperglycemia? *

What is the gender of people who have Hyperglycemia when taking Exelon? *

female: 79.41 %
male: 20.59 %

What is the age of people who have Hyperglycemia when taking Exelon? *

What are other drugs people take besides Exelon? *

What are other side effects people have besides Hyperglycemia? *

Nausea And Vomiting: 12 people, 34.29%
Fall: 11 people, 31.43%
Nausea (feeling of having an urge to vomit): 10 people, 28.57%
Insomnia (sleeplessness): 9 people, 25.71%
Hip Fracture: 9 people, 25.71%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 9 people, 25.71%
Constipation: 8 people, 22.86%
Joint Pain: 7 people, 20.00%
Suicidal Ideation: 7 people, 20.00%
Stress And Anxiety: 7 people, 20.00%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 6 people, 17.14%
High Blood Pressure: 6 people, 17.14%
Diabetes: 3 people, 8.57%
Nausea (feeling of having an urge to vomit): 2 people, 5.71%
Psychotic Disorder: 2 people, 5.71%
Neurodegenerative Disorder (progressive loss of structure or function of neurons and death of neuron): 2 people, 5.71%
Depression: 2 people, 5.71%
High Blood Cholesterol: 2 people, 5.71%
Sleep Disorder: 2 people, 5.71%
Stress And Anxiety: 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Exelon and have Hyperglycemia?

- Check whether Hyperglycemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Exelon:

Exelon (11,060 reports)

Hyperglycemia treatments and more:

Hyperglycemia (48,691 reports)

Browse all side effects of Exelon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperglycemia:

Hyperglycemia (1,657 drugs)

Browse all the conditions that are associated with Hyperglycemia:

Hyperglycemia (2,501 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rivastigmine tartrate (the active ingredients of Exelon) and Exelon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.